Citations (304)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Kerstin MG Brand, Judith Schlachter, Caroline Foch & Emmanuelle Boutmy. (2022) Quality and Characteristics of 4241 Case Reports of Lactic Acidosis in Metformin Users Reported to a Large Pharmacovigilance Database. Therapeutics and Clinical Risk Management 18, pages 1037-1047.
Read now
Read now
Manpreet Sambi, Vanessa Samuel, Bessi Qorri, Sabah Haq, Sergey V Burov, Elena Markvicheva, William Harless & Myron R Szewczuk. (2020) A Triple Combination of Metformin, Acetylsalicylic Acid, and Oseltamivir Phosphate Impacts Tumour Spheroid Viability and Upends Chemoresistance in Triple-Negative Breast Cancer. Drug Design, Development and Therapy 14, pages 1995-2019.
Read now
Read now
Xiao Chen, Dong-Dong Wang & Zhi-Ping Li. (2020) Time course and dose effect of metformin on weight in patients with different disease states. Expert Review of Clinical Pharmacology 13:10, pages 1169-1177.
Read now
Read now
Hasnaa Osama, Ossama M. Sayed, Raghda R. S. Hussein, Mohamed Abdelrahim & Ahmed A. Elberry. (2020) Design, optimization, characterization, and in vivo evaluation of sterosomes as a carrier of metformin for treatment of lung cancer. Journal of Liposome Research 30:2, pages 150-162.
Read now
Read now
Tongzhi Wu, Michael Horowitz & Christopher K. Rayner. (2017) New insights into the anti-diabetic actions of metformin: from the liver to the gut. Expert Review of Gastroenterology & Hepatology 11:2, pages 157-166.
Read now
Read now
Corinna Seliger, Anne-Louise Meyer, Kathrin Renner, Verena Leidgens, Sylvia Moeckel, Birgit Jachnik, Katja Dettmer, Ulrike Tischler, Valeria Gerthofer, Lisa Rauer, Martin Uhl, Martin Proescholdt, Ulrich Bogdahn, Markus J. Riemenschneider, Peter J. Oefner, Marina Kreutz, Arabel Vollmann-Zwerenz & Peter Hau. (2016) Metformin inhibits proliferation and migration of glioblastoma cells independently of TGF-β2. Cell Cycle 15:13, pages 1755-1766.
Read now
Read now
Imran Ali, Iqbal Hussain, Mohd
Marsin Sanagi, Wan
Aini Wan Ibrahim & HassanY. Aboul-Enein. (2015) Analyses of Biguanides and Related Compounds in Biological and Environmental Samples by HPLC. Journal of Liquid Chromatography & Related Technologies 38:3, pages 303-321.
Read now
Read now
Oliver Zolk. (2012) Disposition of metformin: Variability due to polymorphisms of organic cation transporters. Annals of Medicine 44:2, pages 119-129.
Read now
Read now
Eun Ju Bae, Min Joo Cho & Sang Geon Kim. (2007) Metformin Prevents an Adaptive Increase in GSH and Induces Apoptosis Under the Conditions of GSH Deficiency in H4IIE Cells∗
. Journal of Toxicology and Environmental Health, Part A 70:15-16, pages 1371-1380.
Read now
Read now
Michael Stumvoll, Hans-Ulrich Häring & Stephan Matthaei. (2007) Metformin. Endocrine Research 32:1-2, pages 39-57.
Read now
Read now
Articles from other publishers (294)
Mehrnaz Abbasi, Zhaoyang Fan, John A. Dawson & Shu Wang. (2024) Anti-obesity and metabolic benefits of metformin: Comparison of different delivery routes. Journal of Drug Delivery Science and Technology 91, pages 105110.
Crossref
Crossref
Adriana Fernanda K. Vizuete, Fernanda Fróes, Marina Seady, Fernanda Hansen, Rodrigo Ligabue-Braun, Carlos-Alberto Gonçalves & Diogo O. Souza. (2023) A Mechanism of Action of Metformin in the Brain: Prevention of Methylglyoxal-Induced Glutamatergic Impairment in Acute Hippocampal Slices. Molecular Neurobiology.
Crossref
Crossref
Xianmei Liu, Peng Yu, Yujun Xu, Yun Wang, Jin Chen, Fuzhou Tang, Zuquan Hu, Jing Zhou, Lina Liu, Wei Qiu, Yuannong Ye, Yi Jia, Weijuan Yao, Jinhua Long & Zhu Zeng. (2023) Metformin induces tolerogenicity of dendritic cells by promoting metabolic reprogramming. Cellular and Molecular Life Sciences 80:10.
Crossref
Crossref
Marisel Rosell-Díaz & José Manuel Fernández-Real. (2023) Metformin, Cognitive Function, and Changes in the Gut Microbiome. Endocrine Reviews.
Crossref
Crossref
Marc Foretz, Bruno Guigas & Benoit Viollet. (2023) Metformin: update on mechanisms of action and repurposing potential. Nature Reviews Endocrinology 19:8, pages 460-476.
Crossref
Crossref
Samson Mathews Samuel, Elizabeth Varghese, Noothan Jyothi Satheesh, Chris R. Triggle & Dietrich Büsselberg. (2023) Metabolic heterogeneity in TNBCs: A potential determinant of therapeutic efficacy of 2-deoxyglucose and metformin combinatory therapy. Biomedicine & Pharmacotherapy 164, pages 114911.
Crossref
Crossref
Aiyu Peng, Chunmei Gong, Yuanfei Xu, Xiongshun Liang, Xiaoping Chen, Wenxu Hong & Junxia Yan. (2023) Association between organic cation transporter genetic polymorphisms and metformin response and intolerance in T2DM individuals: a systematic review and meta-analysis. Frontiers in Public Health 11.
Crossref
Crossref
Xisto Antonio de Oliveira Neto, Leticia Barssotti, Ana Thereza Fiori-Duarte, Helena Cristina de Lima Barbosa & Daniel Fábio Kawano. (2023) Entering the Sugar Rush Era: Revisiting the Antihyperglycemic
Activities of Biguanides after a Century of Metformin Discovery. Current Medicinal Chemistry 30:22, pages 2542-2561.
Crossref
Crossref
Rawnaq A. Aladhab, Abdulkareem H. Abd, Haider A. Alidrisi & Majid H. Alabbood. (2023) Genetic Polymorphism in the Organic Cation Transporters 1 (OCT1) Gene and its Effect on Therapeutic Efficacy and Gastrointestinal Side Effects of Metformin in Patients with Type 2 Diabetes Mellitus in Basrah/ Southern Iraq.. Biomedical and Pharmacology Journal 16:2, pages 1189-1199.
Crossref
Crossref
Raghad Sabaawi Ibrahim, Shahad Sabaawi Ibrahim, Ahmed El-Naas, Lenka Koklesová, Peter Kubatka & Dietrich Büsselberg. (2023) Could Metformin and Resveratrol Support Glioblastoma Treatment? A Mechanistic View at the Cellular Level. Cancers 15:13, pages 3368.
Crossref
Crossref
Jared Senfeld, Qianman Peng, Yi Shi, Shenqi Qian & Jianzhong Shen. (2023) A purinergic mechanism underlying metformin regulation of hyperglycemia. iScience 26:6, pages 106898.
Crossref
Crossref
Song-Yang Zhang, Kyla Bruce, Zahra Danaei, Rosa J.W. Li, Daniel R. Barros, Rachel Kuah, Yu-Mi Lim, Laura H. Mariani, David Z. Cherney, Jennifer F.M. Chiu, Heather N. Reich & Tony K.T. Lam. (2023) Metformin triggers a kidney GDF15-dependent area postrema axis to regulate food intake and body weight. Cell Metabolism 35:5, pages 875-886.e5.
Crossref
Crossref
Mateusz Pieróg, Katarzyna Socała, Dorota Nieoczym, Elżbieta Wyska, Małgorzata Samorek-Pieróg & Piotr Wlaź. (2023) Anticonvulsant Profile of Selected Medium-Chain Fatty Acids (MCFAs) Co-Administered with Metformin in Mice in Acute and Chronic Treatment. Molecules 28:9, pages 3810.
Crossref
Crossref
Rima Mohsen Chakaroun, Lisa M. Olsson & Fredrik Bäckhed. (2022) The potential of tailoring the gut microbiome to prevent and treat cardiometabolic disease. Nature Reviews Cardiology 20:4, pages 217-235.
Crossref
Crossref
Pingting Ye, Lei Feng, Dan Zhang, Ruihao Li, Yixuan Wen, Xiaohan Tong, Shuo Shi & Chunyan Dong. (2023) Metformin Ameliorates D-Galactose-Induced Senescent Human Bone Marrow-Derived Mesenchymal Stem Cells by Enhancing Autophagy. Stem Cells International 2023, pages 1-14.
Crossref
Crossref
Christopher Huynh, Jaewhee Ryu, Jooho Lee, Ayaka Inoki & Ken Inoki. (2022) Nutrient-sensing mTORC1 and AMPK pathways in chronic kidney diseases. Nature Reviews Nephrology 19:2, pages 102-122.
Crossref
Crossref
Francisco Javier Acebedo-Martínez, Alicia Domínguez-Martín, Carolina Alarcón-Payer, Carolina Garcés-Bastida, Cristóbal Verdugo-Escamilla, Jaime Gómez-Morales & Duane Choquesillo-Lazarte. (2023) Metformin-NSAIDs Molecular Salts: A Path towards Enhanced Oral Bioavailability and Stability. Pharmaceutics 15:2, pages 449.
Crossref
Crossref
Kaori Hozumi, Kenji Sugawara, Takaya Ishihara, Naotada Ishihara & Wataru Ogawa. (2023) Effects of imeglimin on mitochondrial function, AMPK activity, and gene expression in hepatocytes. Scientific Reports 13:1.
Crossref
Crossref
Sahar Rezaei, Khalid A. Timani & Johnny J. He. (2023) Metformin Treatment Leads to Increased HIV Transcription and Gene Expression through Increased CREB Phosphorylation and Recruitment to the HIV LTR Promoter. Aging and disease, pages 0.
Crossref
Crossref
M. Imran, Geetanjali Sachdeva, Shyla Menon, Dhanjit Das, Sravanthi Davuluri, Kshitish Acharya & Uddhav Chaudhari. (2023) Therapeutic metformin concentrations positively regulate proliferation in endometrial epithelial cells via mTOR activation and augmented mitochondrial strength. Canadian Journal of Physiology and Pharmacology 101:1, pages 52-64.
Crossref
Crossref
Kaitlin M Love, Eugene J Barrett & William B Horton. (2022) Metformin's Impact on the Microvascular Response to Insulin. Endocrinology 163:11.
Crossref
Crossref
Chin-Hsiao Tseng. (2022) Metformin and risk of gingival/periodontal diseases in diabetes patients: A retrospective cohort study. Frontiers in Endocrinology 13.
Crossref
Crossref
Johann Roessler, David M. Leistner, Ulf Landmesser & Arash Haghikia. (2022) Modulatory role of gut microbiota in cholesterol and glucose metabolism: Potential implications for atherosclerotic cardiovascular disease. Atherosclerosis 359, pages 1-12.
Crossref
Crossref
Chunjiang Wang, Hongyi Deng, Yunfei Xu & Ying Liu. (2022) Literature review of the clinical characteristics of metformin-induced hepatotoxicity. Frontiers in Pharmacology 13.
Crossref
Crossref
Wenrui Ma, Jingjing Zhang, Shaowen Liu, Shiqiang Yan, Kehua Xu, Yu Shrike Zhang, Mieradilijiang Abudupataer, Yang Ming, Shichao Zhu, Bitao Xiang, Xiaonan Zhou, Shaman Luo, Hui Huang, Yuyi Tang, Shan Zhang, Zhuxin Xie, Nan Chen, Xiaoning Sun, Jun Li, Hao Lai, Chunsheng Wang, Kai Zhu & Weijia Zhang. (2022) Patient-derived microphysiological model identifies the therapeutic potential of metformin for thoracic aortic aneurysm. eBioMedicine 81, pages 104080.
Crossref
Crossref
Qinzhi Yang, Gang Wang, Dan Fang, Xiaojun Gao, Yu Liang, Liqun Wang, Jianbo Wu, Min Zeng & Mao Luo. (2022) The role of MicroRNA networks in tissue-specific direct and indirect effects of metformin and its application. Biomedicine & Pharmacotherapy 151, pages 113130.
Crossref
Crossref
Emre Urhan, Emre Temizer, Zuleyha Karaca, Ummuhan Abdulrezzak, Canan Sehit Kara, Aysa Hacioglu & Kursad Unluhizarci. (2022) The effect of additional acarbose on metformin-associated artificially high 18F-Fluorodeoxyglucose uptake in positron emission tomography/computed tomography. Acta Diabetologica 59:7, pages 929-937.
Crossref
Crossref
Izabela Szymczak-Pajor, Sylwia Wenclewska & Agnieszka Śliwińska. (2022) Metabolic Action of Metformin. Pharmaceuticals 15:7, pages 810.
Crossref
Crossref
Laura Di Magno, Fiorella Di Pastena, Rosa Bordone, Sonia Coni & Gianluca Canettieri. (2022) The Mechanism of Action of Biguanides: New Answers to a Complex Question. Cancers 14:13, pages 3220.
Crossref
Crossref
Armin Mooranian, Jacqueline Chester, Edan Johnston, Corina Mihaela Ionescu, Daniel Walker, Melissa Jones, Susbin Raj Wagle, Bozica Kovacevic, Thomas Foster, Momir Mikov & Hani Al-Salami. (2022) Reduced Cytokine Tumour Necrosis Factor by Pharmacological Intervention in a Preclinical Study. Biomolecules 12:7, pages 877.
Crossref
Crossref
Ying Wang, Zhi Wang, Huiping Yang, Shuze Chen, Dekai Zheng, Xiuying Liu, Qinrui Jiang & Ye Chen. (2022) Metformin Ameliorates Chronic Colitis-Related Intestinal Fibrosis via Inhibiting TGF-β1/Smad3 Signaling. Frontiers in Pharmacology 13.
Crossref
Crossref
Edward Fielder, Tengfei Wan, Ghazaleh Alimohammadiha, Abbas Ishaq, Evon Low, B Melanie Weigand, George Kelly, Craig Parker, Brigid Griffin, Diana Jurk, Viktor I Korolchuk, Thomas von Zglinicki & Satomi Miwa. (2022) Short senolytic or senostatic interventions rescue progression of radiation-induced frailty and premature ageing in mice. eLife 11.
Crossref
Crossref
Cameron A. Schmidt. (2022) Prescription drugs and mitochondrial metabolism. Bioscience Reports 42:4.
Crossref
Crossref
Di Xie, Fan Chen, Yuanyuan Zhang, Bei Shi, Jiahui Song, Kiran Chaudhari, Shao-Hua Yang, Gary J. Zhang, Xiaoli Sun, Hugh S. Taylor, Da Li & Yingqun Huang. (2022) Let-7 underlies metformin-induced inhibition of hepatic glucose production. Proceedings of the National Academy of Sciences 119:14.
Crossref
Crossref
Traci E. LaMoia, Gina M. Butrico, Hasini A. Kalpage, Leigh Goedeke, Brandon T. Hubbard, Daniel F. Vatner, Rafael C. Gaspar, Xian-Man Zhang, Gary W. Cline, Keita Nakahara, Seungwan Woo, Atsuhiro Shimada, Maik Hüttemann & Gerald I. Shulman. (2022) Metformin, phenformin, and galegine inhibit complex IV activity and reduce glycerol-derived gluconeogenesis. Proceedings of the National Academy of Sciences 119:10.
Crossref
Crossref
Mairam Kaplanian, Cecile Philippe, Sameer Abu Eid, Martina T. Hackl, Matthäus Metz, Marianna Beghini, Andreea C. Luca, Alexandra Kautzky-Willer, Thomas Scherer & Clemens Fürnsinn. (2022) Deciphering metformin action in obese mice: A critical re-evaluation of established protocols. Metabolism 128, pages 154956.
Crossref
Crossref
Janis Kurlovics, Darta Maija Zake, Linda Zaharenko, Kristaps Berzins, Janis Klovins & Egils Stalidzans. (2021) Metformin Transport Rates Between Plasma and Red Blood Cells in Humans. Clinical Pharmacokinetics 61:1, pages 133-142.
Crossref
Crossref
Hitomi Tsuchida, Yasuko Morita, Munenobu Nogami & Wataru Ogawa. (2021) Metformin action in the gut―insight provided by [18F]FDG PET imaging. Diabetology International 13:1, pages 35-40.
Crossref
Crossref
Giovanni Tulipano. (2021) Integrated or Independent Actions of Metformin in Target Tissues Underlying Its Current Use and New Possible Applications in the Endocrine and Metabolic Disorder Area. International Journal of Molecular Sciences 22:23, pages 13068.
Crossref
Crossref
Felix B. Meyer, Sophie Goebel, Sonja B. Spangel, Christiane Leovsky, Doerte Hoelzer & René Thierbach. (2021) Metformin alters therapeutic effects in the BALB/c tumor therapy model. BMC Cancer 21:1.
Crossref
Crossref
Arik Dahan, Daniel Porat, Milica Markovic, Moran Zur, Olga Kister & Peter Langguth. (2021) Optimized In Silico Modeling of Drug Absorption after Gastric Bypass: The Case of Metformin. Pharmaceutics 13:11, pages 1873.
Crossref
Crossref
Thomas S. Postler, Vincent Peng, Dev M. Bhatt & Sankar Ghosh. (2021) Metformin selectively dampens the acute inflammatory response through an AMPK-dependent mechanism. Scientific Reports 11:1.
Crossref
Crossref
Amélie Bravard, Céline Gérard, Clémence Defois, Bérengère Benoit, Kassem Makki, Emmanuelle Meugnier, Dominique Rainteau, Jennifer Rieusset, Murielle Godet & Hubert Vidal. (2021) Metformin treatment for 8 days impacts multiple intestinal parameters in high-fat high-sucrose fed mice. Scientific Reports 11:1.
Crossref
Crossref
Ibrahim Mohammed, Morley D. Hollenberg, Hong Ding & Chris R. Triggle. (2021) A Critical Review of the Evidence That Metformin Is a Putative Anti-Aging Drug That Enhances Healthspan and Extends Lifespan. Frontiers in Endocrinology 12.
Crossref
Crossref
Hongxu Xian, Yuan Liu, Alexandra Rundberg Nilsson, Raphaella Gatchalian, Timothy R. Crother, Warren G. Tourtellotte, Yi Zhang, German R. Aleman-Muench, Gavin Lewis, Weixuan Chen, Sarah Kang, Melissa Luevanos, Dorit Trudler, Stuart A. Lipton, Pejman Soroosh, John Teijaro, Juan Carlos de la Torre, Moshe Arditi, Michael Karin & Elsa Sanchez-Lopez. (2021) Metformin inhibition of mitochondrial ATP and DNA synthesis abrogates NLRP3 inflammasome activation and pulmonary inflammation. Immunity 54:7, pages 1463-1477.e11.
Crossref
Crossref
Isabella Panfoli, Alessandra Puddu, Nadia Bertola, Silvia Ravera & Davide Maggi. (2021) The Hormetic Effect of Metformin: “Less Is More”?. International Journal of Molecular Sciences 22:12, pages 6297.
Crossref
Crossref
Yoo-Seong Jeong & William J. Jusko. (2021) Meta-Assessment of Metformin Absorption and Disposition Pharmacokinetics in Nine Species. Pharmaceuticals 14:6, pages 545.
Crossref
Crossref
Carlos Noe Farfan-Morales, Carlos Daniel Cordero-Rivera, Juan Fidel Osuna-Ramos, Irma Eloisa Monroy-Muñoz, Luis Adrián De Jesús-González, José Esteban Muñoz-Medina, Arianna M. Hurtado-Monzón, José Manuel Reyes-Ruiz & Rosa María del Ángel. (2021) The antiviral effect of metformin on zika and dengue virus infection. Scientific Reports 11:1.
Crossref
Crossref
Darta Maija Zake, Janis Kurlovics, Linda Zaharenko, Vitalijs Komasilovs, Janis Klovins & Egils Stalidzans. (2021) Physiologically based metformin pharmacokinetics model of mice and scale-up to humans for the estimation of concentrations in various tissues. PLOS ONE 16:4, pages e0249594.
Crossref
Crossref
Marine Jauvain, Sarah Courtois, Philippe Lehours & Emilie Bessède. (2021) Metformin Modifies the Gut Microbiota of Mice Infected with Helicobacter pylori. Pharmaceuticals 14:4, pages 329.
Crossref
Crossref
Chae Bin Lee, Soon Uk Chae, Seong Jun Jo, Ui Min Jerng & Soo Kyung Bae. (2021) The Relationship between the Gut Microbiome and Metformin as a Key for Treating Type 2 Diabetes Mellitus. International Journal of Molecular Sciences 22:7, pages 3566.
Crossref
Crossref
Larisa Emelyanova, Xiaowen Bai, Yasheng Yan, Zeljko J. Bosnjak, David Kress, Catherine Warner, Stacie Kroboth, Teodore Rudic, Sirisha Kaushik, Elizabeth Stoeckl, Gracious R Ross, Farhan Rizvi, A. Jamil Tajik & Arshad Jahangir. (2021) Biphasic effect of metformin on human cardiac energetics. Translational Research 229, pages 5-23.
Crossref
Crossref
Tsukuru Amano, Atsushi Murakami, Takashi Murakami & Tokuhiro Chano. (2021) Antioxidants and Therapeutic Targets in Ovarian Clear Cell Carcinoma. Antioxidants 10:2, pages 187.
Crossref
Crossref
Traci E LaMoia & Gerald I Shulman. (2021) Cellular and Molecular Mechanisms of Metformin Action. Endocrine Reviews 42:1, pages 77-96.
Crossref
Crossref
Ming Yang, Tamana Darwish, Pierre Larraufie, Debra Rimmington, Irene Cimino, Deborah A. Goldspink, Benjamin Jenkins, Albert Koulman, Cheryl A. Brighton, Marcella Ma, Brian Y. H. Lam, Anthony P. Coll, Stephen O’Rahilly, Frank Reimann & Fiona M. Gribble. (2021) Inhibition of mitochondrial function by metformin increases glucose uptake, glycolysis and GDF-15 release from intestinal cells. Scientific Reports 11:1.
Crossref
Crossref
Andrew Yeh, James P. Meador, Tamara D. Lunsman, David B. Mayfield & Tim A. Verslycke. 2021. Pharmaceuticals in Marine and Coastal Environments. Pharmaceuticals in Marine and Coastal Environments
457
499
.
Marleen J. Meyer, Alzbeta Tuerkova, Sarah Römer, Christoph Wenzel, Tina Seitz, Jochen Gaedcke, Stefan Oswald, Jürgen Brockmöller, Barbara Zdrazil & Mladen V. Tzvetkov. (2020) Differences in Metformin and Thiamine Uptake between Human and Mouse Organic Cation Transporter 1: Structural Determinants and Potential Consequences for Intrahepatic Concentrations. Drug Metabolism and Disposition 48:12, pages 1380-1392.
Crossref
Crossref
Malcolm J. Borg, Christopher K. Rayner, Karen L. Jones, Michael Horowitz, Cong Xie & Tongzhi Wu. (2020) Gastrointestinal Mechanisms Underlying the Cardiovascular Effect of Metformin. Pharmaceuticals 13:11, pages 410.
Crossref
Crossref
Mario Cioce, Claudio Pulito, Sabrina Strano, Giovanni Blandino & Vito Michele Fazio. (2020) Metformin: Metabolic Rewiring Faces Tumor Heterogeneity. Cells 9:11, pages 2439.
Crossref
Crossref
Ling He. (2020) Metformin and Systemic Metabolism. Trends in Pharmacological Sciences 41:11, pages 868-881.
Crossref
Crossref
Gastón Amable, Eduardo Martínez‐León, María Elisa Picco, Sergio I. Nemirovsky, Enrique Rozengurt & Osvaldo Rey. (2020) Metformin inhibition of colorectal cancer cell migration is associated with rebuilt adherens junctions and FAK downregulation. Journal of Cellular Physiology 235:11, pages 8334-8344.
Crossref
Crossref
Maritza P. Garrido, Renato Salvatierra, Manuel Valenzuela-Valderrama, Christopher Vallejos, Nicole Bruneau, Andrea Hernández, Margarita Vega, Alberto Selman, Andrew F. G. Quest & Carmen Romero. (2020) Metformin Reduces NGF-Induced Tumour Promoter Effects in Epithelial Ovarian Cancer Cells. Pharmaceuticals 13:10, pages 315.
Crossref
Crossref
Rene A. Posma, A. Mireille A. Wessels, Willem Dieperink, Jan Roggeveld, Henri G.D. Leuvenink, Iwan C.C. van der Horst, Wilfred F.A. den Dunnen, Maarten W. Nijsten & Daan J. Touw. (2020) Renal Trapping in Accidental Metformin Intoxication. Kidney International Reports 5:9, pages 1525-1528.
Crossref
Crossref
Julia A. Loos, Valeria A. Dávila, Klaus Brehm & Andrea C. Cumino. (2020) Metformin Suppresses Development of the Echinococcus multilocularis Larval Stage by Targeting the TOR Pathway. Antimicrobial Agents and Chemotherapy 64:9.
Crossref
Crossref
Sarah Knoll, Stefanie Jacob, Susanna Mieck, Rita Triebskorn, Thomas Braunbeck & Carolin Huhn. (2020) Development of a capillary electrophoresis–mass spectrometry method for the analysis of metformin and its transformation product guanylurea in biota. Analytical and Bioanalytical Chemistry 412:20, pages 4985-4996.
Crossref
Crossref
Loranne Agius, Brian E. Ford & Shruti S. Chachra. (2020) The Metformin Mechanism on Gluconeogenesis and AMPK Activation: The Metabolite Perspective. International Journal of Molecular Sciences 21:9, pages 3240.
Crossref
Crossref
Yuan Yang, Houyang Chen, Shiqi Weng, Tingting Pan, Wenqiong Chen, Fang Wang, Tao Luo & Yuxin Tang. (2020) In vitro exposure to metformin activates human spermatozoa at therapeutically relevant concentrations. Andrology 8:3, pages 663-670.
Crossref
Crossref
Tabassum Moonira, Shruti S. Chachra, Brian E. Ford, Silvia Marin, Ahmed Alshawi, Natasha S. Adam-Primus, Catherine Arden, Ziad H. Al-Oanzi, Marc Foretz, Benoit Viollet, Marta Cascante & Loranne Agius. (2020) Metformin lowers glucose 6-phosphate in hepatocytes by activation of glycolysis downstream of glucose phosphorylation. Journal of Biological Chemistry 295:10, pages 3330-3346.
Crossref
Crossref
Julia A. Loos, Perla Negro & Andrea C. Cumino. (2020) In vitro anti-echinococcal activity of octreotide: Additive effect of metformin linked to autophagy. Acta Tropica 203, pages 105312.
Crossref
Crossref
Bayew Tsega Abebe, Michael Weiss, Christiane Modess, Tobias Tadken, Danilo Wegner, Marleen J. Meyer, Ulrich Schwantes, Claudia Neumeister, Eberhard Scheuch, Hans‐Ulrich Schulz, Mladen Tzvetkov & Werner Siegmund. (2019) Pharmacokinetic Drug‐Drug Interactions Between Trospium Chloride and Ranitidine Substrates of Organic Cation Transporters in Healthy Human Subjects. The Journal of Clinical Pharmacology 60:3, pages 312-323.
Crossref
Crossref
Anindita De & Gowthamarajan Kuppusamy. (2020) Metformin in breast cancer: preclinical and clinical evidence. Current Problems in Cancer 44:1, pages 100488.
Crossref
Crossref
Maritza P. Garrido, Margarita Vega & Carmen Romero. 2020. Metformin [Working Title]. Metformin [Working Title].
Hermann Koepsell. (2019) Organic Cation Transporters in Health and Disease. Pharmacological Reviews 72:1, pages 253-319.
Crossref
Crossref
M. A. de Laat & M. N. Sillence. (2020) A review of recent developments in the pharmacological prevention and treatment of endocrinopathic laminitis. Animal Production Science 60:18, pages 2111.
Crossref
Crossref
Jonas M. Kristensen, Christian Lillelund, Rasmus Kjøbsted, Jesper B. Birk, Nicoline R. Andersen, Lars Nybo, Karin Mellberg, Anudharan Balendran, Erik A. Richter & Jørgen F. P. Wojtaszewski. (2019) Metformin does not compromise energy status in human skeletal muscle at rest or during acute exercise: A randomised, crossover trial. Physiological Reports 7:23.
Crossref
Crossref
Jung Ok Lee, Min Ju Kang, Won Seok Byun, Shin Ae Kim, Il Hyeok Seo, Jeong Ah. Han, Ji Wook Moon, Ji Hae Kim, Su Jin Kim, Eun Jung Lee, Serk In Park, Sun Hwa Park & Hyeon Soo Kim. (2019) Metformin overcomes resistance to cisplatin in triple-negative breast cancer (TNBC) cells by targeting RAD51. Breast Cancer Research 21:1.
Crossref
Crossref
Yu Wang, Hongying An, Ting Liu, Caolitao Qin, Hiromi Sesaki, Shaodong Guo, Sally Radovick, Mehboob Hussain, Akhil Maheshwari, Fredric E. Wondisford, Brian O’Rourke & Ling He. (2019) Metformin Improves Mitochondrial Respiratory Activity through Activation of AMPK. Cell Reports 29:6, pages 1511-1523.e5.
Crossref
Crossref
Marc Foretz, Bruno Guigas & Benoit Viollet. (2019) Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus. Nature Reviews Endocrinology 15:10, pages 569-589.
Crossref
Crossref
Fatemeh Khatami, Mohammad R. Mohajeri-Tehrani & Seyed M. Tavangar. (2019) The Importance of Precision Medicine in Type 2 Diabetes Mellitus (T2DM): From Pharmacogenetic and Pharmacoepigenetic Aspects. Endocrine, Metabolic & Immune Disorders - Drug Targets 19:6, pages 719-731.
Crossref
Crossref
Gastón Amable, Eduardo Martínez-León, María Elisa Picco, Nicolas Di Siervi, Carlos Davio, Enrique Rozengurt & Osvaldo Rey. (2019) Metformin inhibits β-catenin phosphorylation on Ser-552 through an AMPK/PI3K/Akt pathway in colorectal cancer cells. The International Journal of Biochemistry & Cell Biology 112, pages 88-94.
Crossref
Crossref
Adem Y. Dawed, Kaixin ZhouNienke van Leeuwen, Anubha MahajanNeil RobertsonRobert Koivula, Petra J.M. Elders, Simone P. Rauh, Angus G. JonesReinhard W. Holl, Julia C. Stingl, Paul W. Franks, Mark I. McCarthyLeen M. ‘t Hart, Ewan R. Pearson, C. Jennison, B. Ehrhardt, P. Baum, C. Schoelsch, J.I. Freijer, R. Grempler, U. Graefe-Mody, A.M. Hennige, C. Dings, T. Lehr, N. Scherer, I. Sihinecich, F. Pattou, V. Raverdi, R. Caiazzo, F. Torres, H. Verkindt, A. Mari, A. Tura, T. Giorgino, R. Bizzotto, P. Froguel, A. Bonneford, M. Canouil, V. Dhennin, C.A. Brorsson, S. Brunak, F. De Masi, V. Gudmundsdóttir, H.K. Pedersen, K. Banasik, E. Thomas, W. Sackett, H. Staerfeldt, A.T. Lundgaard, B. Nilsson, A.M. Nielsen, G. Mazzoni, T. Karaderi, S. Rasmussen, J. Johansen, R.L. Allesøe, A. Fritsche, B. Thorand, J. Adamski, H. Grallert, M. Haid, S. Sharma, M. Troll, J. Adam, J. Ferrer, P. Froguel, R.G. Eriksen, G. Frost, R. Haussler, M.-G. Hong, J.M. Schwenk, M. Uhlen, C. Nicolay, I. Pavo, B. Steckel-Hamann, M.K. Thomas, K. Adragni, H. Wu, L.M. 't Hart, R.C. Roderick, N. van Leeuwen, K.F. Dekkers, F. Frau, J. Gassenhuber, B. Jablonka, P. Musholt, H. Ruetten, J. Tillner, T. Baltauss, O. Bernard, N. Poenaru, M. de Preville, M. Rodriquez, K.H. Arumugam, L. Allin, T. Engelbrechtsen, T.H. Hansen, A. Hansen, A. Forman, O. Jonsson, A. Pedersen, J.K. Dutta, H. Vogt, M. Vestergaard, T. Laakso, T. Kokkola, P.W. Kuulasmaa, G.N. Franks, H. Giordano, H. Pomares-Millan, P. Fitipaldi, M. Mutie, M. Klintenberg, L. Bergstrom, M. Groop, N. Ridderstrale, H.A. Atabaki Pasdar, A.J. Deshmukh, D. Heggie, D. Wake, I. McEvoy, M. McVittie, A.T. Walker, A.V. Hattersley, A.G. Hill, T.J. Jones, M.H. McDonald, R. Perry, M. Nice, C.E. Hudson, E.T. Thorne, A. Dermitzakis, L. Viñuela, H. Cabrelli, A.Y. Loftus, L. Dawed, I.M. Donnelly, E.R. Forgie, C.N. Pearson, A.A. Palmer, R.W. Brown, A. Koivula, M. Wesolowska-Andersen, N. Abdalla, J. McRobert, J. Fernandez, M. Kaye, A. Mourby, M.I. Mahajan, N. McCarthy, H. Shah, Y. Teare, N. Jiao, S. Robertson, R.W. Gough, A.D. Holl, F. Koopman, J.W. Rutters, L. Beulens, A.D. Groeneveld, J.D. Koopman, E.L. Bell, Thomas & B. Whitcher. (2019)
Variation in the Plasma Membrane Monoamine Transporter (PMAT) (Encoded by
SLC29A4
) and Organic Cation Transporter 1 (OCT1) (Encoded by
SLC22A1
) and Gastrointestinal Intolerance to Metformin in Type 2 Diabetes: An IMI DIRECT Study
. Diabetes Care 42:6, pages 1027-1033.
Crossref
Crossref
Armen Yerevanian & Alexander A. Soukas. (2019) Metformin: Mechanisms in Human Obesity and Weight Loss. Current Obesity Reports 8:2, pages 156-164.
Crossref
Crossref
Diana BrickuteMarta Braga, Maciej A. KaliszczakChris BarnesDoreen LauLaurence CarrollElizabeth StevensSebastian TrousilIsrat S. AlamQuang-Dé NguyenEric O. Aboagye. (2019)
Development and Evaluation of an
18
F-Radiolabeled Monocyclam Derivative for Imaging CXCR4 Expression
. Molecular Pharmaceutics 16:5, pages 2106-2117.
Crossref
Crossref
Hong Ding, Kevin Ye & Chris R Triggle. (2019) Impact of currently used anti-diabetic drugs on myoendothelial communication. Current Opinion in Pharmacology 45, pages 1-7.
Crossref
Crossref
Kira Derkach, Irina Zakharova, Inna Zorina, Andrey Bakhtyukov, Irina Romanova, Liubov Bayunova & Alexander Shpakov. (2019) The evidence of metabolic-improving effect of metformin in Ay/a mice with genetically-induced melanocortin obesity and the contribution of hypothalamic mechanisms to this effect. PLOS ONE 14:3, pages e0213779.
Crossref
Crossref
Ahmed Alshawi & Loranne Agius. (2019) Low metformin causes a more oxidized mitochondrial NADH/NAD redox state in hepatocytes and inhibits gluconeogenesis by a redox-independent mechanism. Journal of Biological Chemistry 294:8, pages 2839-5691.
Crossref
Crossref
Wenjun Li, Kiran Chaudhari, Ritu Shetty, Ali Winters, Xiaofei Gao, Zeping Hu, Woo-Ping Ge, Nathalie Sumien, Michael Forster, Ran Liu & Shao-Hua Yang. (2019) Metformin Alters Locomotor and Cognitive Function and Brain Metabolism in Normoglycemic Mice. Aging and disease 10:5, pages 949.
Crossref
Crossref
Tsukasa Nozu, Saori Miyagishi, Shima Kumei, Rintaro Nozu, Kaoru Takakusaki & Toshikatsu Okumura. (2018) Metformin inhibits visceral allodynia and increased gut permeability induced by stress in rats. Journal of Gastroenterology and Hepatology 34:1, pages 186-193.
Crossref
Crossref
Carles Cantó. 2019. Mitochondria in Obesity and Type 2 Diabetes. Mitochondria in Obesity and Type 2 Diabetes
399
418
.
Eva-Maria Blumrich & Ralf Dringen. (2017) Metformin Accelerates Glycolytic Lactate Production in Cultured Primary Cerebellar Granule Neurons. Neurochemical Research 44:1, pages 188-199.
Crossref
Crossref
Raphaëlle Corremans, Benjamin A. Vervaet, Patrick C. D’Haese, Ellen Neven & Anja Verhulst. (2018) Metformin: A Candidate Drug for Renal Diseases. International Journal of Molecular Sciences 20:1, pages 42.
Crossref
Crossref
Mariël F. van Stee, Albert A. de Graaf & Albert K. Groen. (2018) Actions of metformin and statins on lipid and glucose metabolism and possible benefit of combination therapy. Cardiovascular Diabetology 17:1.
Crossref
Crossref
Chrysi Xintaropoulou, Carol Ward, Alan Wise, Suzanna Queckborner, Arran Turnbull, Caroline O. Michie, Alistair R. W. Williams, Tzyvia Rye, Charlie Gourley & Simon P. Langdon. (2018) Expression of glycolytic enzymes in ovarian cancers and evaluation of the glycolytic pathway as a strategy for ovarian cancer treatment. BMC Cancer 18:1.
Crossref
Crossref
Stefanie Jacob, Andreas Dötsch, Sarah Knoll, Heinz-R. Köhler, Eike Rogall, Dominic Stoll, Selina Tisler, Carolin Huhn, Thomas Schwartz, Christian Zwiener & Rita Triebskorn. (2018) Does the antidiabetic drug metformin affect embryo development and the health of brown trout (Salmo trutta f. fario)?. Environmental Sciences Europe 30:1.
Crossref
Crossref
Asma Nafisa, Susan G. Gray, Yingnan Cao, Tinghuai Wang, Suowen Xu, Feroza H. Wattoo, Michael Barras, Neale Cohen, Danielle Kamato & Peter J. Little. (2018) Endothelial function and dysfunction: Impact of metformin. Pharmacology & Therapeutics 192, pages 150-162.
Crossref
Crossref
Francesco Prattichizzo, Angelica Giuliani, Emanuela Mensà, Jacopo Sabbatinelli, Valeria De Nigris, Maria Rita Rippo, Lucia La Sala, Antonio Domenico Procopio, Fabiola Olivieri & Antonio Ceriello. (2018) Pleiotropic effects of metformin: Shaping the microbiome to manage type 2 diabetes and postpone ageing. Ageing Research Reviews 48, pages 87-98.
Crossref
Crossref
Melanie Faure, Michael J. Bertoldo, Rita Khoueiry, Alice Bongrani, François Brion, Cecilia Giulivi, Joelle Dupont & Pascal Froment. (2018) Metformin in Reproductive Biology. Frontiers in Endocrinology 9.
Crossref
Crossref
Kunal Maniar, Vandana Singh, Amal Moideen, Rajasri Bhattacharyya, Amitava Chakrabarti & Dibyajyoti Banerjee. (2018) Inhalational supplementation of metformin butyrate: A strategy for prevention and cure of various pulmonary disorders. Biomedicine & Pharmacotherapy 107, pages 495-506.
Crossref
Crossref
Ales Vancura, Pengli Bu, Madhura Bhagwat, Joey Zeng & Ivana Vancurova. (2018) Metformin as an Anticancer Agent. Trends in Pharmacological Sciences 39:10, pages 867-878.
Crossref
Crossref
Tingting Zhou, Xin Xu, Mengfan Du, Tong Zhao & Jiaying Wang. (2018) A preclinical overview of metformin for the treatment of type 2 diabetes. Biomedicine & Pharmacotherapy 106, pages 1227-1235.
Crossref
Crossref
Robert R. Henry, Juan P. Frias, Brandon Walsh, Sharon Skare, John Hemming, Colleen Burns, Thomas A. Bicsak, Alain Baron & Mark Fineman. (2018) Improved glycemic control with minimal systemic metformin exposure: Effects of Metformin Delayed-Release (Metformin DR) targeting the lower bowel over 16 weeks in a randomized trial in subjects with type 2 diabetes. PLOS ONE 13:9, pages e0203946.
Crossref
Crossref
Eman M. Migdadi, Aaron J. Courtenay, Ismaiel A. Tekko, Maelíosa T.C. McCrudden, Mary-Carmel Kearney, Emma McAlister, Helen O. McCarthy & Ryan F. Donnelly. (2018) Hydrogel-forming microneedles enhance transdermal delivery of metformin hydrochloride. Journal of Controlled Release 285, pages 142-151.
Crossref
Crossref
Ritwika Mallik & Tahseen A. Chowdhury. (2018) Metformin in cancer. Diabetes Research and Clinical Practice 143, pages 409-419.
Crossref
Crossref
Ji‐Chang Wang, Xin Sun, Qiang Ma, Gui‐Feng Fu, Long‐Long Cong, Hong Zhang, De‐Fu Fan, Jun Feng, Shao‐Ying Lu, Jian‐Lin Liu, Guang‐Yue Li & Pei‐Jun Liu. (2018) Metformin's antitumour and anti‐angiogenic activities are mediated by skewing macrophage polarization. Journal of Cellular and Molecular Medicine 22:8, pages 3825-3836.
Crossref
Crossref
Kunal Maniar, Vandana Singh, Amitava Chakrabarti, Rajasri Bhattacharyya & Dibyajyoti Banerjee. (2018) High dose targeted delivery on cancer sites and the importance of short-chain fatty acids for metformin's action: Two crucial aspects of the wonder drug. Regulatory Toxicology and Pharmacology 97, pages 15-16.
Crossref
Crossref
Laura J. McCreight, Tore B. Stage, Paul Connelly, Mike Lonergan, Flemming Nielsen, Cornelia Prehn, Jerzy Adamski, Kim Brøsen & Ewan R. Pearson. (2018) Pharmacokinetics of metformin in patients with gastrointestinal intolerance. Diabetes, Obesity and Metabolism 20:7, pages 1593-1601.
Crossref
Crossref
Dian Chen, Ying Wang, Kaikai Wu & Xingya Wang. (2018) Dual Effects of Metformin on Adipogenic Differentiation of 3T3-L1 Preadipocyte in AMPK-Dependent and Independent Manners. International Journal of Molecular Sciences 19:6, pages 1547.
Crossref
Crossref
Aparajita Verma, Laurie J. Rich, Vui King Vincent-Chong & Mukund Seshadri. (2018) Visualizing the effects of metformin on tumor growth, vascularity, and metabolism in head and neck cancer. Journal of Oral Pathology & Medicine 47:5, pages 484-491.
Crossref
Crossref
Cinzia Antognelli, Rodolfo Cecchetti, Francesca Riuzzi, Matthew J. Peirce & Vincenzo N. Talesa. (2018)
Glyoxalase 1 sustains the metastatic phenotype of prostate cancer cells via
EMT
control
. Journal of Cellular and Molecular Medicine 22:5, pages 2865-2883.
Crossref
Crossref
Laura Paleari, Jürgen Burhenne, Johanna Weiss, Sebastian Foersch, Wilfried Roth, Andrea Parodi, Michael Gnant, Thomas Bachleitner-Hofmann, Dominique Scherer, Cornelia M. Ulrich, Borut Stabuc, Matteo Puntoni, Gianni Coccia, Marilena Petrera, Walter-Emil Haefeli & Andrea DeCensi. (2018) High Accumulation of Metformin in Colonic Tissue of Subjects With Diabetes or the Metabolic Syndrome. Gastroenterology 154:5, pages 1543-1545.
Crossref
Crossref
Paul Kim, Giovanna Piraino, Michael O’Connor, Paul W. Hake, Vivian Wolfe, Patrick Lahni & Basilia Zingarelli. (2018) Metformin Exerts Beneficial Effects in Hemorrhagic Shock in An AMPKα1-Independent Manner. Shock 49:3, pages 277-287.
Crossref
Crossref
Giulio Calza, Elisabeth Nyberg, Matias Mäkinen, Rabah Soliymani, Annunziata Cascone, Dan Lindholm, Emanuele Barborini, Marc Baumann, Maciej Lalowski & Ove Eriksson. (2018) Lactate-Induced Glucose Output Is Unchanged by Metformin at a Therapeutic Concentration – A Mass Spectrometry Imaging Study of the Perfused Rat Liver. Frontiers in Pharmacology 9.
Crossref
Crossref
Nadia Boudaba, Allison Marion, Camille Huet, Rémi Pierre, Benoit Viollet & Marc Foretz. (2018) AMPK Re-Activation Suppresses Hepatic Steatosis but its Downregulation Does Not Promote Fatty Liver Development. EBioMedicine 28, pages 194-209.
Crossref
Crossref
Maritza P. Garrido, Carolina Vera, Margarita Vega, Andrew F.G. Quest & Carmen Romero. (2018) Metformin prevents nerve growth factor-dependent proliferative and proangiogenic effects in epithelial ovarian cancer cells and endothelial cells. Therapeutic Advances in Medical Oncology 10, pages 175883591877098.
Crossref
Crossref
Raquel Díez, Juan José García, María José Diez, Matilde Sierra, Ana M. Sahagun & Nélida Fernández. (2017) Influence of Plantago ovata husk (dietary fiber) on the bioavailability and other pharmacokinetic parameters of metformin in diabetic rabbits. BMC Complementary and Alternative Medicine 17:1.
Crossref
Crossref
Roberta Malaguarnera, Veronica Vella, Maria Luisa Nicolosi & Antonino Belfiore. (2017) Insulin Resistance: Any Role in the Changing Epidemiology of Thyroid Cancer?. Frontiers in Endocrinology 8.
Crossref
Crossref
Jean-Daniel Lalau, Farshad Kajbaf, Alessandro Protti, Mette M. Christensen, Marc E. De Broe & Nicolas Wiernsperger. (2017) Metformin-associated lactic acidosis (MALA): Moving towards a new paradigm. Diabetes, Obesity and Metabolism 19:11, pages 1502-1512.
Crossref
Crossref
Michele D Calder, Nicole A Edwards, Dean H Betts & Andrew J Watson. (2017) Treatment with AICAR inhibits blastocyst development, trophectoderm differentiation and tight junction formation and function in mice. MHR: Basic science of reproductive medicine 23:11, pages 771-785.
Crossref
Crossref
Irina A. Okkelman, Tara Foley, Dmitri B. Papkovsky & Ruslan I. Dmitriev. (2017) Live cell imaging of mouse intestinal organoids reveals heterogeneity in their oxygenation. Biomaterials 146, pages 86-96.
Crossref
Crossref
Michaela C. Hohnholt, Eva‐Maria Blumrich*, Helle S. Waagepetersen & Ralf Dringen. (2017) The antidiabetic drug metformin decreases mitochondrial respiration and tricarboxylic acid cycle activity in cultured primary rat astrocytes. Journal of Neuroscience Research 95:11, pages 2307-2320.
Crossref
Crossref
Veronica Zingales, Alfio Distefano, Marco Raffaele, Antonio Zanghi, Ignazio Barbagallo & Luca Vanella. (2017) Metformin: A Bridge between Diabetes and Prostate Cancer. Frontiers in Oncology 7.
Crossref
Crossref
Dzmitry Matsiukevich, Giovanna Piraino, Patrick Lahni, Paul W. Hake, Vivian Wolfe, Michael O'Connor, Jeanne James & Basilia Zingarelli. (2017) Metformin ameliorates gender-and age-dependent hemodynamic instability and myocardial injury in murine hemorrhagic shock. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1863:10, pages 2680-2691.
Crossref
Crossref
Jukka P. Koffert, Kirsi Mikkola, Kirsi A. Virtanen, Anna-Maria D. Andersson, Linda Faxius, Kirsti Hällsten, Mikael Heglind, Letizia Guiducci, Tam Pham, Johanna M.U. Silvola, Jenni Virta, Olof Eriksson, Saila P. Kauhanen, Antti Saraste, Sven Enerbäck, Patricia Iozzo, Riitta Parkkola, Maria F. Gomez & Pirjo Nuutila. (2017) Metformin treatment significantly enhances intestinal glucose uptake in patients with type 2 diabetes: Results from a randomized clinical trial. Diabetes Research and Clinical Practice 131, pages 208-216.
Crossref
Crossref
Clifford J. Bailey. (2017) Metformin: historical overview. Diabetologia 60:9, pages 1566-1576.
Crossref
Crossref
Ziad H. Al-Oanzi, Sophia Fountana, Tabassum Moonira, Susan J. Tudhope, John L. Petrie, Ahmed Alshawi, Gillian Patman, Catherine Arden, Helen L. Reeves & Loranne Agius. (2017) Opposite effects of a glucokinase activator and metformin on glucose-regulated gene expression in hepatocytes. Diabetes, Obesity and Metabolism 19:8, pages 1078-1087.
Crossref
Crossref
Xin Yang, Zhipeng Xu, Chunlan Zhang, Zixin Cai & Jingjing Zhang. (2017) Metformin, beyond an insulin sensitizer, targeting heart and pancreatic β cells. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1863:8, pages 1984-1990.
Crossref
Crossref
Hong Lu. (2017) Crosstalk of 5′-Monophosphate-Activated Protein Kinase (AMPK) with Extracellular and Intracellular Signaling Pathways in the Regulation of Nutrient Metabolism and Cell Survival in the Liver. Current Pharmacology Reports 3:4, pages 162-175.
Crossref
Crossref
H. Liang, W. Xu, L. Zhou, W. Yang & J. Weng. (2017) Differential increments of basal glucagon-like-1 peptide concentration among SLC47A1 rs2289669 genotypes were associated with inter-individual variability in glycaemic response to metformin in Chinese people with newly diagnosed Type 2 diabetes. Diabetic Medicine 34:7, pages 987-992.
Crossref
Crossref
Philipp Schommers, Anna Thurau, Insa Bultmann-Mellin, Maria Guschlbauer, Andreas R. Klatt, Jan Rozman, Martin Klingenspor, Martin Hrabe de Angelis, Jens Alber, Dirk Gründemann, Anja Sterner-Kock & Rudolf J. Wiesner. (2017) Metformin causes a futile intestinal–hepatic cycle which increases energy expenditure and slows down development of a type 2 diabetes-like state. Molecular Metabolism 6:7, pages 737-747.
Crossref
Crossref
Daisuke Sato, Katsutaro Morino, Fumiyuki Nakagawa, Koichiro Murata, Osamu Sekine, Fumiaki Beppu, Naohiro Gotoh, Satoshi Ugi & Hiroshi Maegawa. (2017) Acute Effect of Metformin on Postprandial Hypertriglyceridemia through Delayed Gastric Emptying. International Journal of Molecular Sciences 18:6, pages 1282.
Crossref
Crossref
Jaeryun Lee, Deokbae Park & Youngki Lee. (2017) Metformin Synergistically Potentiates the Antitumor Effects of Imatinib in Colorectal Cancer Cells. Development & Reproduction 21:2, pages 139-150.
Crossref
Crossref
Xiangcheng Zhang, Futai Shang, Liangliang Hui, Kui Zang & Gengyun Sun. (2017) The alleviative effects of metformin for lipopolysaccharide-induced acute lung injury rat model and its underlying mechanism. Saudi Pharmaceutical Journal 25:4, pages 666-670.
Crossref
Crossref
Ntsoaki Annah Nyane, Thabiso Bethwel Tlaila, Tanki Gabriel Malefane, Dudu Edith Ndwandwe & Peter Mark Oroma Owira. (2017) Metformin-like antidiabetic, cardio-protective and non-glycemic effects of naringenin: Molecular and pharmacological insights. European Journal of Pharmacology 803, pages 103-111.
Crossref
Crossref
Andy E. Durham. (2017) Therapeutics for Equine Endocrine Disorders. Veterinary Clinics of North America: Equine Practice 33:1, pages 127-139.
Crossref
Crossref
Ayesha S. Khan & Daniel E. Frigo. (2017) A spatiotemporal hypothesis for the regulation, role, and targeting of AMPK in prostate cancer. Nature Reviews Urology 14:3, pages 164-180.
Crossref
Crossref
Inès Gouaref, Dominique Detaille, Nicolas Wiernsperger, Naim Akhtar Khan, Xavier Leverve & Elhadj-Ahmed Koceir. (2017) The desert gerbil Psammomys obesus as a model for metformin-sensitive nutritional type 2 diabetes to protect hepatocellular metabolic damage: Impact of mitochondrial redox state. PLOS ONE 12:2, pages e0172053.
Crossref
Crossref
Julia A. Loos, Valeria A. Dávila, Christian R. Rodrígues, Romina Petrigh, Jorge A. Zoppi, Fernando A. Crocenzi & Andrea C. Cumino. (2017) Metformin exhibits preventive and therapeutic efficacy against experimental cystic echinococcosis. PLOS Neglected Tropical Diseases 11:2, pages e0005370.
Crossref
Crossref
Andy E. Durham. 2017. Equine Laminitis. Equine Laminitis
329
333
.
K M Biernacka, R A Persad, A Bahl, D Gillatt, J M P Holly & C M Perks. (2017) Hyperglycaemia-induced resistance to Docetaxel is negated by metformin: a role for IGFBP-2. Endocrine-Related Cancer 24:1, pages 17-30.
Crossref
Crossref
Floriana Morgillo, Morena Fasano, Carminia Maria Della Corte, Ferdinando Carlo Sasso, Federica Papaccio, Giuseppe Viscardi, Giovanna Esposito, Raimondo Di Liello, Nicola Normanno, Annalisa Capuano, Liberato Berrino, Giovanni Vicidomini, Alfonso Fiorelli, Mario Santini & Fortunato Ciardiello. (2017) Results of the safety run-in part of the METAL (METformin in Advanced Lung cancer) study: a multicentre, open-label phase I–II study of metformin with erlotinib in second-line therapy of patients with stage IV non-small-cell lung cancer. ESMO Open 2:2, pages e000132.
Crossref
Crossref
C. R. Triggle & H. Ding. (2017) Metformin is not just an antihyperglycaemic drug but also has protective effects on the vascular endothelium. Acta Physiologica 219:1, pages 138-151.
Crossref
Crossref
Yoshihito Fujita & Nobuya Inagaki. (2017) Metformin: New Preparations and Nonglycemic Benefits. Current Diabetes Reports 17:1.
Crossref
Crossref
Yansong Xue, Hanying Zhang, Xiaofei Sun & Mei-Jun Zhu. (2016) Metformin Improves Ileal Epithelial Barrier Function in Interleukin-10 Deficient Mice. PLOS ONE 11:12, pages e0168670.
Crossref
Crossref
Sanjana Chowdhury, Eric Yung, Melania Pintilie, Hala Muaddi, Selim Chaib, ManTek Yeung, Manlio Fusciello, Jenna Sykes, Bethany Pitcher, Anna Hagenkort, Trevor McKee, Ravi Vellanki, Eric Chen, Robert G. Bristow, Bradly G. Wouters & Marianne Koritzinsky. (2016) MATE2 Expression Is Associated with Cancer Cell Response to Metformin. PLOS ONE 11:12, pages e0165214.
Crossref
Crossref
Lars C. Gormsen, Elias Immanuel Sundelin, Jonas Brorson Jensen, Mikkel Holm Vendelbo, Steen Jakobsen, Ole Lajord Munk, Mette Marie Hougaard Christensen, Kim Brøsen, Jørgen Frøkiær & Niels Jessen. (2016)
In Vivo Imaging of Human
11
C-Metformin in Peripheral Organs: Dosimetry, Biodistribution, and Kinetic Analyses
. Journal of Nuclear Medicine 57:12, pages 1920-1926.
Crossref
Crossref
Yan-rong Ma, A-xi Shi, Hong-yan Qin, Tiffany Zhang, Yan-fang Wu, Guo-qiang Zhang & Xin-an Wu. (2016) Metoprolol decreases the plasma exposure of metformin via the induction of liver, kidney and muscle uptake in rats. Biopharmaceutics & Drug Disposition 37:9, pages 511-521.
Crossref
Crossref
Tanja DujicKaixin ZhouRoger TavendaleColin N.A. PalmerEwan R. Pearson. (2016) Effect of Serotonin Transporter 5-HTTLPR Polymorphism on Gastrointestinal Intolerance to Metformin: A GoDARTS Study. Diabetes Care 39:11, pages 1896-1901.
Crossref
Crossref
Suk Hyun Lee, Soyoung Jin, Hyo Sang Lee, Jin-Sook Ryu & Jong Jin Lee. (2016) Metformin discontinuation less than 72 h is suboptimal for F-18 FDG PET/CT interpretation of the bowel. Annals of Nuclear Medicine 30:9, pages 629-636.
Crossref
Crossref
Anna J. AndersonRuth AndrewNatalie Z. HomerGregory C. JonesKenneth Smith, Dawn E. LivingstoneBrian R. WalkerRoland H. Stimson. (2016) Metformin Increases Cortisol Regeneration by 11βHSD1 in Obese Men With and Without Type 2 Diabetes Mellitus. The Journal of Clinical Endocrinology & Metabolism 101:10, pages 3787-3793.
Crossref
Crossref
Giada Poli, Giulia Cantini, Roberta Armignacco, Rossella Fucci, Raffaella Santi, Letizia Canu, Gabriella Nesi, Massimo Mannelli & Michaela Luconi. (2016) Metformin as a new anti-cancer drug in adrenocortical carcinoma. Oncotarget 7:31, pages 49636-49648.
Crossref
Crossref
Julie Eakins, Caroline Bauch, Heather Woodhouse, Benjamin Park, Samantha Bevan, Clive Dilworth & Paul Walker. (2016) A combined in vitro approach to improve the prediction of mitochondrial toxicants. Toxicology in Vitro 34, pages 161-170.
Crossref
Crossref
Ralph A. DeFronzo, John B. Buse, Terri Kim, Colleen Burns, Sharon Skare, Alain Baron & Mark Fineman. (2016) Once-daily delayed-release metformin lowers plasma glucose and enhances fasting and postprandial GLP-1 and PYY: results from two randomised trials. Diabetologia 59:8, pages 1645-1654.
Crossref
Crossref
Galo L. Mejia, Marina N. Asiedu, Yasumichi Hitoshi, Gregory Dussor & Theodore J. Price. (2016) The potent, indirect adenosine monophosphate-activated protein kinase activator R419 attenuates mitogen-activated protein kinase signaling, inhibits nociceptor excitability, and reduces pain hypersensitivity in mice. PAIN Reports 1:1, pages e562.
Crossref
Crossref
Maruša Rajh, Klemen Dolinar, Katarina Miš, Mojca Pavlin & Sergej Pirkmajer. (2016) Medium Renewal Blocks Anti-Proliferative Effects of Metformin in Cultured MDA-MB-231 Breast Cancer Cells. PLOS ONE 11:5, pages e0154747.
Crossref
Crossref
Tao Yang, Sibo Wang, Xuyong Zhang, Jie Xia, Jun Guo, Jixue Hou, Hongwei Zhang, Xueling Chen & Xiangwei Wu. (2016) A Rapid and Convenient Method for in Vivo Fluorescent Imaging of Protoscolices of <i>Echinococcus multilocularis</i>. The Korean Journal of Parasitology 54:2, pages 225-231.
Crossref
Crossref
T. Dujic, A. Causevic, T. Bego, M. Malenica, Z. Velija-Asimi, E. R. Pearson & S. Semiz. (2016) Organic cation transporter 1 variants and gastrointestinal side effects of metformin in patients with Type 2 diabetes. Diabetic Medicine 33:4, pages 511-514.
Crossref
Crossref
Morgan D. Fullerton. (2016) AMP-activated protein kinase and its multifaceted regulation of hepatic metabolism. Current Opinion in Lipidology 27:2, pages 172-180.
Crossref
Crossref
Farshad Kajbaf, Marc E. De Broe & Jean-Daniel Lalau. (2015) Therapeutic Concentrations of Metformin: A Systematic Review. Clinical Pharmacokinetics 55:4, pages 439-459.
Crossref
Crossref
Joanne S. Allard, Evelyn J. Perez, Koji Fukui, Priscilla Carpenter, Donald K. Ingram & Rafael de Cabo. (2016) Prolonged metformin treatment leads to reduced transcription of Nrf2 and neurotrophic factors without cognitive impairment in older C57BL/6J mice. Behavioural Brain Research 301, pages 1-9.
Crossref
Crossref
Laura J. McCreight, Clifford J. Bailey & Ewan R. Pearson. (2016) Metformin and the gastrointestinal tract. Diabetologia 59:3, pages 426-435.
Crossref
Crossref
William R. Proctor, Xin Ming, David Bourdet, Tianxiang (Kevin) Han, Ruth S. Everett & Dhiren R. Thakker. (2016) Why Does the Intestine Lack Basolateral Efflux Transporters for Cationic Compounds? A Provocative Hypothesis. Journal of Pharmaceutical Sciences 105:2, pages 484-496.
Crossref
Crossref
Hongying An & Ling He. (2016) Current understanding of metformin effect on the control of hyperglycemia in diabetes. Journal of Endocrinology 228:3, pages R97-R106.
Crossref
Crossref
F. Kajbaf, Y. Bennis, A.-S. Hurtel-Lemaire, M. Andréjak & J.-D. Lalau. (2016) Unexpectedly long half-life of metformin elimination in cases of metformin accumulation. Diabetic Medicine 33:1, pages 105-110.
Crossref
Crossref
Erli Zhang, Qianyun Guo, Haiyang Gao, Ruixia Xu, Siyong Teng & Yongjian Wu. (2015) Metformin and Resveratrol Inhibited High Glucose-Induced Metabolic Memory of Endothelial Senescence through SIRT1/p300/p53/p21 Pathway. PLOS ONE 10:12, pages e0143814.
Crossref
Crossref
Federica Barbieri, Stefano Thellung, Alessandra Ratto, Elisa Carra, Valeria Marini, Carmen Fucile, Adriana Bajetto, Alessandra Pattarozzi, Roberto Würth, Monica Gatti, Chiara Campanella, Guendalina Vito, Francesca Mattioli, Aldo Pagano, Antonio Daga, Angelo Ferrari & Tullio Florio. (2015) In vitro and in vivo antiproliferative activity of metformin on stem-like cells isolated from spontaneous canine mammary carcinomas: translational implications for human tumors. BMC Cancer 15:1.
Crossref
Crossref
Rosina PryorFilipe Cabreiro. (2015) Repurposing metformin: an old drug with new tricks in its binding pockets. Biochemical Journal 471:3, pages 307-322.
Crossref
Crossref
Sook Wah Yee, Lawrence Lin, Matthew Merski, Michael J. Keiser, Aakash Gupta, Youcai Zhang, Huan-Chieh Chien, Brian K. Shoichet & Kathleen M. Giacomini. (2015) Prediction and validation of enzyme and transporter off-targets for metformin. Journal of Pharmacokinetics and Pharmacodynamics 42:5, pages 463-475.
Crossref
Crossref
Chrysi Xintaropoulou, Carol Ward, Alan Wise, Hugh Marston, Arran Turnbull & Simon P. Langdon. (2015) A comparative analysis of inhibitors of the glycolysis pathway in breast and ovarian cancer cell line models. Oncotarget 6:28, pages 25677-25695.
Crossref
Crossref
Silvia Bruno, Bernardetta Ledda, Claudya Tenca, Silvia Ravera, Anna Maria Orengo, Andrea Nicola Mazzarello, Elisa Pesenti, Salvatore Casciaro, Omar Racchi, Fabio Ghiotto, Cecilia Marini, Gianmario Sambuceti, Andrea DeCensi & Franco Fais. (2015) Metformin inhibits cell cycle progression of B-cell chronic lymphocytic leukemia cells. Oncotarget 6:26, pages 22624-22640.
Crossref
Crossref
Wen Yue, Xi Zheng, Yong Lin, Chung S. Yang, Qing Xu, Darren Carpizo, Huarong Huang, Robert S. DiPaola & Xiang-Lin Tan. (2015)
Metformin combined with aspirin significantly inhibit pancreatic cancer cell growth
in vitro
and
in vivo
by suppressing anti-apoptotic proteins Mcl-1 and Bcl-2
. Oncotarget 6:25, pages 21208-21224.
Crossref
Crossref
Wen Yue, Tao Wang, Emmanuel Zachariah, Yong Lin, Chung S. Yang, Qing Xu, Robert S. DiPaola & Xiang-Lin Tan. (2015) Transcriptomic analysis of pancreatic cancer cells in response to metformin and aspirin: an implication of synergy. Scientific Reports 5:1.
Crossref
Crossref
Fang Xie, Alice B. Ke, Gary D. Bowers & Maciej J. Zamek-Gliszczynski. (2015) Metformin's Intrinsic Blood-to-Plasma Partition Ratio (B/P): Reconciling the Perceived High In Vivo B/P > 10 with the In Vitro Equilibrium Value of Unity. Journal of Pharmacology and Experimental Therapeutics 354:2, pages 225-229.
Crossref
Crossref
Y. Huang, J. Sun, X. Wang, X. Tao, H. Wang & W. Tan. (2015) Asymptomatic chronic gastritis decreases metformin tolerance in patients with type 2 diabetes. Journal of Clinical Pharmacy and Therapeutics 40:4, pages 461-465.
Crossref
Crossref
Rebecca J. Ford, Morgan D. Fullerton, Stephen L. Pinkosky, Emily A. Day, John W. Scott, Jonathan S. Oakhill, Adam L. Bujak, Brennan K. Smith, Justin D. Crane, Regje M. Blümer, Katarina Marcinko, Bruce E. Kemp, Hertzel C. Gerstein & Gregory R. Steinberg. (2015) Metformin and salicylate synergistically activate liver AMPK, inhibit lipogenesis and improve insulin sensitivity. Biochemical Journal 468:1, pages 125-132.
Crossref
Crossref
Julia A. Loos & Andrea C. Cumino. (2015) In Vitro Anti-Echinococcal and Metabolic Effects of Metformin Involve Activation of AMP-Activated Protein Kinase in Larval Stages of Echinococcus granulosus. PLOS ONE 10:5, pages e0126009.
Crossref
Crossref
Tanja Dujic, Kaixin ZhouLouise A. DonnellyRoger TavendaleColin N.A. PalmerEwan R. Pearson. (2015) Association of Organic Cation Transporter 1 With Intolerance to Metformin in Type 2 Diabetes: A GoDARTS Study. Diabetes 64:5, pages 1786-1793.
Crossref
Crossref
Frank A Duca, Clémence D Côté, Brittany A Rasmussen, Melika Zadeh-Tahmasebi, Guy A Rutter, Beatrice M Filippi & Tony K T Lam. (2015) Metformin activates a duodenal Ampk–dependent pathway to lower hepatic glucose production in rats. Nature Medicine 21:5, pages 506-511.
Crossref
Crossref
Haruo Kato, Yoshitaka Sekine, Yosuke Furuya, Yoshiyuki Miyazawa, Hidekazu Koike & Kazuhiro Suzuki. (2015) Metformin inhibits the proliferation of human prostate cancer PC-3 cells via the downregulation of insulin-like growth factor 1 receptor. Biochemical and Biophysical Research Communications 461:1, pages 115-121.
Crossref
Crossref
Christina S. Han, Melissa A. Herrin, Mary C. Pitruzzello, Melissa J. Mulla, Erika F. Werner, Christian M. Pettker, Clare A. Flannery & Vikki M. Abrahams. (2015) Glucose and Metformin Modulate Human First Trimester Trophoblast Function: a Model and Potential Therapy for Diabetes-Associated Uteroplacental Insufficiency. American Journal of Reproductive Immunology 73:4, pages 362-371.
Crossref
Crossref
Zaid H. Maayah, Hazem Ghebeh, Abdulqader A. Alhaider, Ayman O.S. El-Kadi, Anatoly A. Soshilov, Michael S. Denison, Mushtaq Ahmad Ansari & Hesham M. Korashy. (2015) Metformin inhibits 7,12-dimethylbenz[a]anthracene-induced breast carcinogenesis and adduct formation in human breast cells by inhibiting the cytochrome P4501A1/aryl hydrocarbon receptor signaling pathway. Toxicology and Applied Pharmacology 284:2, pages 217-226.
Crossref
Crossref
Huan He, Rong Ke, Hui Lin, Ying Ying, Dan Liu & Zhijun Luo. (2015) Metformin, an Old Drug, Brings a New Era to Cancer Therapy. The Cancer Journal 21:2, pages 70-74.
Crossref
Crossref
Georg Karpel-Massler, Richard Eric Kast, Mike-Andrew Westhoff, Annika Dwucet, Nathalie Welscher, Lisa Nonnenmacher, Michal Hlavac, Markus David Siegelin, Christian Rainer Wirtz, Klaus-Michael Debatin & Marc-Eric Halatsch. (2014) Olanzapine inhibits proliferation, migration and anchorage-independent growth in human glioblastoma cell lines and enhances temozolomide’s antiproliferative effect. Journal of Neuro-Oncology 122:1, pages 21-33.
Crossref
Crossref
TAKASHI UEHARA, AKIRA MITSUHASHI, NOBUHIDE TSURUOKA & MAKIO SHOZU. (2015) Metformin potentiates the anticancer effects of cisplatin under normoxic conditions in vitro. Oncology Reports 33:2, pages 744-750.
Crossref
Crossref
Zachary A. P. Wintrob. (2015) Should Pharmacokinetic Safety Challenges Prevent Metformin Use in Patients With Cancer?. Journal of Pharmacy Practice 28:1, pages 48-49.
Crossref
Crossref
Yuxin HuangJiao SunXingsi WangXiaoming TaoHaidong WangWen Tan. (2015)
Helicobacter pylori
Infection Decreases Metformin Tolerance in Patients with Type 2 Diabetes Mellitus
. Diabetes Technology & Therapeutics 17:2, pages 128-133.
Crossref
Crossref
Jean-Daniel Lalau, Paul Arnouts, Adnan Sharif & Marc E. De Broe. (2015) Metformin and other antidiabetic agents in renal failure patients. Kidney International 87:2, pages 308-322.
Crossref
Crossref
Ling He & Fredric E. Wondisford. (2015) Metformin Action: Concentrations Matter. Cell Metabolism 21:2, pages 159-162.
Crossref
Crossref
Igor Vujic, Martina Sanlorenzo, Christian Posch, Rosaura Esteve-Puig, Adam J. Yen, Andrew Kwong, Aaron Tsumura, Ryan Murphy, Klemens Rappersberger & Susana Ortiz-Urda. (2014)
Metformin and trametinib have synergistic effects on cell viability and tumor growth in
NRAS
mutant cancer
. Oncotarget 6:2, pages 969-978.
Crossref
Crossref
Mustafa Kinaan, Hong Ding & Chris R. Triggle. (2015) Metformin: An Old Drug for the Treatment of Diabetes but a New Drug for the Protection of the Endothelium. Medical Principles and Practice 24:5, pages 401-415.
Crossref
Crossref
Agnieszka Śmieszek, Katarzyna Basińska, Klaudia Chrząstek & Krzysztof Marycz. (2015)
In Vitro
and
In Vivo
Effects of Metformin on Osteopontin Expression in Mice Adipose-Derived Multipotent Stromal Cells and Adipose Tissue
. Journal of Diabetes Research 2015, pages 1-16.
Crossref
Crossref
Displaying 200 of 304 citing articles. Use the download link below to view the full list of citing articles.
Download full citations list